Want to boost your portfolio? Don’t miss these high-conviction funds!
Want to boost your portfolio? Don’t miss these high-conviction funds!

Want to boost your portfolio? Don’t miss these high-conviction funds!

Thematic funds are steadily gaining investor attention, thanks to their promising potential. But what exactly are these funds, and how can they add an edge to your portfolio? Let’s dive in

DSIJ Intelligence Article rating: 5.0

Thematic funds are steadily gaining investor attention, thanks to their promising potential. But what exactly are these funds, and how can they add an edge to your portfolio? Let’s dive in

Stocks Sold by Mutual Funds in March 2025
Stocks Sold by Mutual Funds in March 2025

Stocks Sold by Mutual Funds in March 2025

As markets rallied, mutual funds booked profits and pared down holdings across large-cap, mid-cap, and small-cap stocks — here’s a look at where the selling happened.

DSIJ Intelligence Article rating: 5.0

As markets rallied, mutual funds booked profits and pared down holdings across large-cap, mid-cap, and small-cap stocks — here’s a look at where the selling happened.

Mutual Funds Pick Their Bets: Stocks Bought in March 2025
Mutual Funds Pick Their Bets: Stocks Bought in March 2025

Mutual Funds Pick Their Bets: Stocks Bought in March 2025

Despite a choppy market and declining inflows, mutual funds continued to bet on select large-cap, mid-cap, and small-cap stocks — here’s a look at what they bought.

DSIJ Intelligence Article rating: 5.0

Despite a choppy market and declining inflows, mutual funds continued to bet on select large-cap, mid-cap, and small-cap stocks — here’s a look at what they bought.

Top Performing Pharma and Healthcare Mutual Funds in Last 3 Years
Top Performing Pharma and Healthcare Mutual Funds in Last 3 Years

Top Performing Pharma and Healthcare Mutual Funds in Last 3 Years

Indian pharmaceutical stocks surged 5 per cent on Thursday, defying a broader market decline, following the U.S. administration's decision to exempt pharmaceutical products from new reciprocal tariffs.

DSIJ Intelligence-2 Article rating: 5.0

Indian pharmaceutical stocks surged 5 per cent on Thursday, defying a broader market decline, following the U.S. administration's decision to exempt pharmaceutical products from new reciprocal tariffs.

Equity Mutual Fund Inflows Drop 26 per cent to Rs 29,303 Crore in February as AUM Falls 4.04 per cent Amid Market Correction; Rs 6,525 Crore Outflow in Debt Schemes
Equity Mutual Fund Inflows Drop 26 per cent to Rs 29,303 Crore in February  as AUM Falls 4.04 per cent Amid Market Correction; Rs 6,525 Crore Outflow in Debt Schemes

Equity Mutual Fund Inflows Drop 26 per cent to Rs 29,303 Crore in February as AUM Falls 4.04 per cent Amid Market Correction; Rs 6,525 Crore Outflow in Debt Schemes

The total inflows standing at Rs 40,063 crore in February compared to Rs 1,87,550 crore in January, according to data from the Association of Mutual Funds of India (AMFI) released on March 12.

DSIJ Intelligence-2 Article rating: 5.0
RSS
1345678910Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR